Table of Contents
A patent portfolio analysis Eindhoven innovators can take to a board or a licensing table has to start where the value is created — in the fabs, cleanrooms and design labs of the Brainport region. Eindhoven sits at the centre of the world’s densest patent cluster: businesses in and around the city are granted roughly four patents a day, more than half of every patent filed in the Netherlands, and the region trails only Munich and Paris among Europe’s patenting urban areas. That concentration of semiconductor, photonics and high-tech estates makes the questions asked of a portfolio here technical and commercial at once: what is truly protected, what is merely registered, and what would actually hold up in The Hague?
The work is landscape, gap, strength and valuation analysis — not litigation. It is the diligence behind a cross-licensing deal with a chip maker, the schedule a scale-up on the High Tech Campus shows a growth investor, and the renewal-fee decision that stops a large estate quietly overspending year after year. PerspireIP delivers that read for the R&D leaders, IP counsel and deal teams running Eindhoven portfolios.
Why patent portfolio analysis Eindhoven teams start at the fab
In most cities a portfolio review begins with the technology. Around Eindhoven it begins with the fab and the supply chain that feeds it. This is the home region of ASML, whose EUV lithography systems every advanced-chip maker in the world depends on; of NXP Semiconductors; of Signify, the lighting business spun out of Philips; and of Philips itself, still the single largest Dutch applicant at the European Patent Office. Their patents, and those of the suppliers and TU/e spin-offs around them, are the collateral, the cross-licence currency and the freedom-to-operate risk in every deal the cluster does.
That setting changes what a study must deliver. A landscape map is not academic here — it is an exhibit in a technology-transfer or M&A data room. A strength score is not a curiosity — it is a number that moves a cross-licensing balance. We build a patent portfolio analysis Eindhoven corporate-development teams, investment committees and CFOs can act on, tied to the deal or the budget cycle that prompted it.
- Cross-licensing and joint development — the validity, scope and essentiality of what each side brings to a semiconductor or photonics deal
- M&A and growth-equity diligence — ownership chain, encumbrances and product coverage of a target’s Dutch and European patents
- Scale-up financing — an honest read of whether the IP backs a High Tech Campus founder’s story to a growth investor
- Board and budget reviews — a periodic strength, gap and renewal-cost picture for the CFO and general counsel
The Dutch registration patent means analysis, not the grant, proves strength
A Dutch national patent is granted very differently from a U.S. or examined European one, and that changes everything about how you must read the estate. The Netherlands runs a registration system: Octrooicentrum Nederland, part of the RVO, performs only a novelty search and grants the patent once the formalities are met — regardless of what that search finds. There is no substantive examination of novelty or inventive step before grant.
The practical consequence is stark. A granted Dutch registration patent — a registratieoctrooi — tells you almost nothing about whether its claims are valid. Validity is genuinely tested only later, in court or by the kind of analysis a buyer’s or licensee’s counsel will run. An estate that looks strong on a grant count can be thin once the prior art is laid against the claims, and an owner who has never had the portfolio analysed simply does not know which side of that line each asset falls on.
It is a common and expensive surprise: a Brainport company enters a licensing talk or a sale believing it holds fifty granted Dutch patents, only to find that a fraction would survive a serious validity attack — while the counterparty has already run exactly that analysis.
This is why analysis matters more in the Netherlands than in examined jurisdictions, not less. We grade each significant Dutch asset the way an opponent would — how crowded the prior art is, how broad the independent claims are, how the family would fare if challenged — so you learn the real strength of the estate before a counterparty does it for you.
Reading a dense semiconductor and photonics estate
Semiconductor and photonics portfolios are unlike almost any other. They are deep, densely layered and heavily cross-licensed: no single company can ship an advanced chip or a lithography tool without touching patents held by dozens of others, so the cluster runs on cross-licences and freedom-to-operate clearances rather than on litigation. Reading such an estate means mapping not just what you own but what you are exposed to and what you can trade.
The strategic prize is the chokepoint patent. In lithography, advanced packaging or a photonics process, a handful of narrowly held patents can gate an entire manufacturing step — the reason a portfolio around a fab is worth far more than its raw count suggests. We identify which of your assets sit on those chokepoints and which third-party patents sit on yours, because that map sets the terms of every cross-licence and supply agreement in the region.
In a supplier-dense ecosystem where a single blocked step can idle a production line, knowing exactly where your leverage lies — and where a rival could squeeze you — is the difference between negotiating a cross-licence from strength and paying to unblock one under pressure.
- Freedom-to-operate mapping — which third-party patents read on your process, product or roadmap before you commit a fab line
- Cross-licence valuation — what each side genuinely brings, so the balancing payment reflects real strength, not patent counts
- Chokepoint identification — the narrow, high-leverage patents that gate a manufacturing step, yours and your rivals’
- Standard-essential exposure — the connectivity, video and interface standards your chips and devices implement, as liability and as asset
The Hague’s exclusive jurisdiction and the UPC Local Division
Portfolio risk is partly forum risk, and in the Netherlands the forum is unusually concentrated. The District Court of The Hague (Rechtbank Den Haag) holds exclusive jurisdiction over Dutch patent infringement and validity disputes, with appeals to the Hague Court of Appeal. There is no regional patchwork: every Dutch patent case is decided by one specialist court with a dedicated patent bench, so an Eindhoven portfolio can be graded against a single, coherent body of case law.
Since June 2023 that same city also hosts a Local Division of the Unified Patent Court. The UPC Local Division in The Hague hears infringement and revocation actions on European patents with unitary effect and on classical European patents that have not been opted out, sitting in a multinational panel of three legally qualified judges — several of them the same experienced patent judges who sit in the District Court. Its early caseload, including the closely watched Moderna dispute, shows it is a live venue, not a theoretical one.
For a portfolio owner that means two overlapping systems to plan for. A Dutch national registration patent is enforced only in The Hague under Dutch law; a European patent may now be litigated centrally at the UPC across all member states at once, or kept out of it by an opt-out. We flag which of your assets sit in which system, and which are most exposed to a fast, pan-European revocation, so the estate can be strengthened or pruned before a dispute rather than during one.
Landscape, gap and white-space analysis across the Brainport cluster
The offensive side of portfolio work is finding what you do not yet own. A landscape maps the patents held by you and your competitors across a technology area; a gap or white-space analysis then shows where protectable, commercially useful inventions sit unclaimed — the ground your R&D leaders should file into before a rival does. In a cluster as dense as Brainport, that white space is narrow and moves fast.
The region gives the exercise unusual depth. Around Eindhoven the competitive set is concentrated and legible: ASML and its suppliers in lithography, NXP in automotive and secure chips, Signify in lighting and photonics, imec-NL and Eindhoven University of Technology spin-offs across the emerging edges, and industrials such as VDL and DAF Trucks nearby. Mapping filing trends across those assignees shows not just where the white space is but where each competitor is heading — intelligence a filing programme can actually steer by.
- Competitive landscape maps — who holds what across your technology space, by assignee, claim scope and filing trend
- Gap and white-space analysis — the unclaimed, protectable ground to direct the next filing programme
- Strength and coverage scoring — how well the portfolio actually reads on your products and roadmap
- Assignee and inventor tracking — where ASML, NXP, Signify, Philips and the TU/e ecosystem are filing next
Renewal-fee pruning and the unitary patent decision
The fastest return a portfolio review delivers is usually a cut, not a filing. Dutch national patents carry annual renewal fees payable to Octrooicentrum Nederland from the fourth year onward, and European patents carry escalating annual renewals that rise sharply with age. Across an estate of hundreds of assets spanning Dutch, European and unitary rights, the annuity bill runs well into six or seven figures — much of it spent on patents that no longer read on a live product or block a competitor.
A pruning analysis scores every asset against three tests before its next fee falls due: does it still cover a shipping product or a roadmap item, does it block a competitor, and would a licensee or buyer pay for it. Assets that fail all three are candidates to drop at the next renewal window, and for a large Eindhoven estate the exercise typically pays for itself many times over at the first decision it informs.
The unitary patent adds a second lever. Since 2023 a granted European patent can take unitary effect — a single renewal fee covering all participating states, priced at roughly the cost of renewing in four countries — or follow the classical route of national validations the owner can prune country by country. Which route is cheaper depends entirely on how many countries an asset truly needs, and that is a portfolio question. We model both paths per family so the renewal budget matches the commercial footprint.
How PerspireIP builds a portfolio analysis you can act on
Every engagement follows the same disciplined path, scaled to whether you are prepping a data room, negotiating a cross-licence or defending a budget. We inventory the portfolio, verify legal status and ownership, map each asset to products and competitors, grade strength and validity exposure, and price the estate for the transaction or decision that prompted the review.
- Full inventory with legal-status, term and renewal timeline for every Dutch, European and unitary asset
- Product-to-patent coverage mapping and a claim-strength score across the estate
- Validity grading of the significant assets against the prior art, the way an opponent would
- Freedom-to-operate, chokepoint and cross-licence maps, with standard-essential exposure where relevant
- Renewal-fee pruning tied to your next Octrooicentrum Nederland and EPO windows, with a unitary-versus-classical model
- A valuation view for M&A, financing, licensing or collateral, delivered as data-room-ready exhibits
We work alongside your in-house IP team, corporate-development group or outside counsel as a specialist analysis partner, deliver to your deal or budget calendar, and keep every engagement confidential. Whether you need a one-time diligence study before a Brainport acquisition, an annual portfolio health check for the board, or an ongoing landscaping and pruning programme, we scale to fit. Send us the assignee name or a patent list and we will scope a patent portfolio analysis Eindhoven project within one business day.
IP Landscape & Resources in Eindhoven
Key intellectual-property authorities and venues relevant to Eindhoven:
- Octrooicentrum Nederland (Netherlands Patent Office, RVO) — grants Dutch registration patents after a novelty search only, with no substantive examination, so an estate's true strength is revealed by analysis rather than by the grant
- Unified Patent Court (UPC) — operates the Local Division in The Hague, which hears infringement and revocation actions on unitary and non-opted-out European patents across the member states
- European Patent Office (EPO) — grants European and unitary patents and publishes the filing data behind Brainport landscape, gap and renewal-versus-unitary decisions
- World Intellectual Property Organization (WIPO) — PATENTSCOPE — global patent-family and publication data used for landscape, gap and white-space analysis across jurisdictions
Request a Patent Portfolio Analysis in Eindhoven
Request a Patent Portfolio Analysis in Eindhoven
Get a landscape, gap, strength and valuation study built for a Brainport cross-licence, M&A deal, board review or filing programme — with validity grading on the Dutch registration patents that only analysis can test, and renewal-fee pruning tied to your next Octrooicentrum Nederland and EPO windows. Send us the assignee name or a patent list and we will scope the work within one business day.
Explore related PerspireIP services: Patent Portfolio Analysis services · IP services in the Netherlands · patent invalidation · prior art litigation search · patent infringement analysis · patent market research.
Frequently Asked Questions
What is a patent portfolio analysis, and how is it different from litigation work?
A patent portfolio analysis is a commercial and strategic review of the patents a company owns or is considering acquiring — a landscape of the competitive field, a gap or white-space map of what is unclaimed, a strength and coverage score against the products, and a valuation for a deal or a board. It is diligence and strategy, not enforcement: we are not litigating a case, we are telling you what the estate is worth, where it is weak, and what to file, keep or abandon. For Eindhoven clients that usually supports a cross-licensing negotiation, an M&A transaction, or the annual renewal-fee budget.
Why does a Dutch registration patent make analysis more important?
Because the Netherlands does not substantively examine patents before grant. Octrooicentrum Nederland runs a registration system: it carries out a novelty search but grants the patent once the formalities are met, regardless of what that search finds. So a granted Dutch patent — a registratieoctrooi — tells you little about whether its claims are actually valid; validity is only tested later, in court or by analysis. We grade each significant Dutch asset against the prior art the way an opponent would, so you learn the real strength of the estate before a counterparty does.
Where would our Eindhoven patents be litigated if a dispute arose?
The District Court of The Hague (Rechtbank Den Haag) holds exclusive jurisdiction over Dutch patent infringement and validity disputes, with appeals to the Hague Court of Appeal — there is no separate patent venue in Eindhoven or elsewhere in the Netherlands. Since June 2023 The Hague also hosts a Local Division of the Unified Patent Court, which hears cases on unitary and non-opted-out European patents. We fold both forums into your portfolio’s risk map so you know which assets are exposed to Dutch-only enforcement and which to a fast, pan-European UPC action.
How do you handle the dense semiconductor and photonics estates common around Eindhoven?
These portfolios are deep and heavily cross-licensed — no one ships an advanced chip or a lithography tool without touching patents held by many others — so we read them as a trading position, not just an inventory. We map your freedom to operate against third-party patents, identify the chokepoint patents that gate a manufacturing step, and value what each side genuinely brings to a cross-licence. That is the intelligence that sets the terms of the supply and licensing agreements the Brainport cluster runs on, and it is analysis rather than litigation.
Should we take unitary effect or validate European patents nationally?
It depends on the commercial footprint of each family, and that is a portfolio decision we model for you. Since 2023 a granted European patent can take unitary effect — one renewal fee covering all participating states, roughly the cost of renewing in four countries — or follow the classical route of national validations you can prune country by country. If an asset only needs a few markets, classical validation is often cheaper; if it needs broad coverage, unitary usually wins. We run both paths per family against your renewal budget.
How does a portfolio review cut our renewal-fee spend?
Dutch national patents carry annual renewal fees to Octrooicentrum Nederland from the fourth year, and European patents carry renewals that escalate steeply with age; across a large estate that is a six- or seven-figure annual bill, much of it on patents that no longer cover a product or block a competitor. A pruning analysis scores each asset before its next window against product coverage, competitive value and resale value, so you stop paying for the assets that fail all three — a cut that usually pays for the whole review at the first decision it informs.
Which Eindhoven and Brainport companies and sectors do you most often analyze?
The Brainport region is the densest patent cluster in the world — roughly four patents a day, more than half of all Dutch filings — so the estates are concentrated in high tech. We regularly analyze semiconductor and lithography portfolios in the orbit of ASML and NXP, photonics and lighting estates around Signify and Philips, and the deep-tech IP coming out of imec-NL, the High Tech Campus and Eindhoven University of Technology spin-offs, plus industrials such as VDL and DAF. Each estate is read on its own technical and commercial terms rather than by patent count.